Cargando…
Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
INTRODUCTION: Preterm birth complicates >15 million pregnancies annually worldwide. In many countries, women who present with signs of preterm labour are treated with tocolytics for 48 hours. Although this delays birth, it has never been shown to improve neonatal outcome. In 2015, the WHO stated...
Autores principales: | Klumper, Job, Breebaart, Wouter, Roos, Carolien, Naaktgeboren, Christiana A, van der Post, Joris, Bosmans, Judith, van Kaam, Anton, Schuit, Ewoud, Mol, Ben W, Baalman, Jelle, McAuliffe, Fionnuala, Thornton, Jim, Kok, Marjolein, Oudijk, Martijn A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887072/ https://www.ncbi.nlm.nih.gov/pubmed/31772083 http://dx.doi.org/10.1136/bmjopen-2019-029101 |
Ejemplares similares
-
Effects of tocolysis with nifedipine or atosiban on child outcome: follow‐up of the APOSTEL III trial
por: van Winden, TMS, et al.
Publicado: (2020) -
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)
por: van Vliet, Elvira OG, et al.
Publicado: (2014) -
Correction: Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
Publicado: (2022) -
Questionnaire survey on women’s views after a first caesarean delivery in two tertiary centres in Ireland and their preference for involvement in a future randomised trial on mode of birth
por: Ryan, Gillian, et al.
Publicado: (2019) -
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis
por: van Winden, Tijn M. S., et al.
Publicado: (2022)